Benspiro Tablets are a prescription cardiac medication for dogs, developed by Vivaldis Animal Health and approved by the U.S. FDA. Specially formulated for the treatment of congestive heart failure (CHF) in dogs, Benspiro is indicated for cases caused by atrioventricular valvular insufficiency (AVVI) and myxomatous mitral valve disease (MMVD). This advanced dual-action formula is the first of its kind brought to India by Vivaldis.
Benspiro combines two active ingredients – Spironolactone and Benazepril – to provide comprehensive support for dogs suffering from heart conditions. It is available in easy-to-administer chewable tablets, making it suitable for long-term therapy in affected dogs.
Composition (Per Chewable Tablet):
- Spironolactone 40 mg + Benazepril 5 mg
- OR
- Spironolactone 80 mg + Benazepril 10 mg (depending on variant chosen)
Indications and Uses:
Benspiro is indicated for:
- Congestive Heart Failure (CHF) in dogs
- CHF due to atrioventricular valvular insufficiency (AVVI)
- Heart conditions related to myxomatous mitral valve disease (MMVD)
- Long-term management of dogs with chronic cardiac dysfunction
Directions for Use:
- Dosage: As directed by the veterinarian
- The dose may vary based on the dog’s weight, age, and severity of the condition
- Always follow veterinary guidance for optimal therapeutic outcomes
Net Quantity:
- Pack of 3 strips (10 tablets each)
- Total: 30 chewable tablets
Suitable for: Dogs only
- Not intended for use in cats or other species
Disclaimer:
Supertails is dedicated to providing expert-reviewed, accurate, and trustworthy information. However, this content is intended solely for informational purposes and should not replace professional veterinary advice. It may not cover all possible medical scenarios, side effects, drug interactions, or warnings. Always consult your veterinarian for diagnosis, treatment options, and dosage recommendations for your pet’s specific condition.

Reviews
There are no reviews yet.